Pdt Partners, LLC Applied Genetic Technologies Corp Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.28 - $7.15 $42,408 - $132,990	-18,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.85 - $7.35 $8,085 - $15,435	2,100 Added 12.73%	18,600 $136,000
Q1 2018 May 15, 2018	BUY	$3.65 - $5.2 $19,345 - $27,560	5,300 Added 47.32%	16,500 $64,000
Q4 2017 Feb 14, 2018	SELL	$3.4 - $4.15 $19,995 - $24,406	-5,881 Reduced 34.43%	11,200 $40,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $60,637 - $89,675	17,081	17,081 $67,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.